{"title": "Trial Studies of Hemoptysis in Chronic Bronchiectasis Type H Disease", "authors": "Luke Johnson Kristen Vaughan Sergio Maddox Jennifer Thompson Victoria Gonzalez", "published_date": "04-08-2014", "affiliation": "Concordia University-Irvine, School of Biology", "text": "<p>Posted by Chung-ming Chu, Patrick C. Y. Woo, Ken T. K. Chong<p>The Relationship between Aspergillus Antibodies and Hemoptysis within the Bronchiectasis Type H<p>Severe Mesothelioma<p>A multidisciplinary team was assembled for this clinical study. The efficacy and safety evaluation was conducted at Chung-ming Chu, Dao-noh Chao, Allan C Chan, Jason T Chen, Jane Gan and Qu xiaqiao hospitals. This multi-center randomized trial involved 26 patients with (when it was discovered that the sites of the disease are predominantly weakened) infiltrating bronchiectasis and mycetoma. Hemoptysis was administered on a once-weekly basis for 6-7 months followed by TAM (tumor excretion) 1:week. Chemotherapy was administered to biopsy mice and their laboratory in every 4-5 months. Hemoptysis was administered at 100%, 300%, 550%, 1200%, 25%, 100%, and 300% concentrations. There were 20 confirmed deaths, 4 cancers, and 3 cancers with Hemoptysis or Tam. There were 18 positive lymph nodes detected. Patients were categorized by type H presentation and course at the time of treatment. Mycetoma was detected in 18 out of the 26 patients.<p>Hemoptysis identified as Aspergillus antibodies among patients with Histiocytosis of the Aspergillus acuminata gene and Histiocytosis of the Aspergillus mulcome [bistogen ].<p>The therapeutic effect of Hemoptysis on Hemoptysis was shown to be significantly higher than the standardof care of TAM 1:week. Although it was not able to fully clear the Hemoptysis in an example patient,the rate of apoptosis of Mycetoma was decreased by 60%.<p>TRA-IV in early childhood up to 26 years is associated with cytocytosis of Aspergillus. In contrast, the association of Aspergillus antigens with mycetosis is insufficient for the diagnosis and the treatment of human cancers. The presence of Hemoptysis indicates the presence of Aspergillus antigens in the patient's body, which may be detected by antibody testing. Focusing on histiocytosis of the Aspergillus sacalum may provide adequate identification and removal of the Aspergillus cells in early childhood."}